Blog

BC Seniors Advocate Wants To Change Conversation Around Aging

Seniors Week ended in BC on June 9, 2018. Isobel MacKenzie, Seniors Advocate for BC wants to use more positive language when discussion older citizens of BC. For example, we should not say that seniors are a problem to be solved or a cost curve to be bent. We should be talking about the fact Read more about BC Seniors Advocate Wants To Change Conversation Around Aging[…]

CMA “Demand a National Seniors Strategy for Healthcare”

Close to 17% of Canada’s population is 65 or older. By 2031, Statistics Canada projects that one in four Canadians will be seniors.

With Canada’s population aging, maintaining the status quo for seniors health care is not an option. Our health care system was designed a half-century ago, and it has not kept pace with the issues of the elderly in Canada. Today, seniors need better solutions, services and support.

Faced with that reality, the Canadian Medical Association (CMA) has been demanding that a national seniors strategy be implemented by 2019.

[…]

Estimated Cost of Universal Public Coverage of Prescription Drugs in Canada

An article published an article in the Canadian Medical Association Journal (CMAJ) estimates the cost of universal public coverage of prescription drugs in Canada. The authors are Steven G. Morgan PhD, Michael Law PhD, Jamie R. Daw BHSc, MSc, Liza Abraham BSc, and Danielle Martin MD, MPubPol.

This is a summary of that article.

With the exception of Canada, all countries with universal health insurance systems provide universal coverage of prescription drugs. Progress toward universal public drug coverage in Canada has been slow, in part because of concerns about the potential costs. The authors sought to estimate the cost of implementing universal public coverage of prescription drugs in Canada.

[…]

Social Isolation, a Growing Epidemic

The Prime Minister of the United Kingdom recently appointed one of her ministers, Tracey Crouch, to lead an inter-governmental group tasked with countering a growing epidemic of social isolation and loneliness.

The appointment was made in response to a report published by the Commission on Loneliness, set up to honor the late Jo Cox, a Labour MP who had campaigned about loneliness and was murdered by a right wing extremist in 2016.

In her announcement Prime Minister May said: “For far too many people, loneliness is the sad reality of modern life.” and “I want to confront this challenge for our society and for all of us to take action to address the loneliness endured by the elderly, by carers, by those who have lost loved ones – people who have no one to talk to or share their thoughts and experiences with.”

[…]

NAFTA Negotiations Threaten Canada’s Push for Universal Pharmacare

NAFTA re-negotiations may impact Canada’s push for Universal Pharmacare. U.S. trade negotiators favour the interests of pharmaceutical manufacturers over government and consumers. In the 1980s, the U.S. pharmaceutical industry successfully lobbied the U.S. government to make the elimination of early generic drug competition in Canada part of the Canada-U.S. free trade agreement. In the 1990s, The Read more about NAFTA Negotiations Threaten Canada’s Push for Universal Pharmacare[…]

Quebec Implementing Single Purchaser for Generic Drugs

Summary of the Globe and Mail article Quebec expects to save millions with overhaul of generic-drug purchasing process Quebec will seek competitive bids from companies for exclusive supply contracts for generic prescription drugs In Quebec, pharmacists were often rebated up to 45 per cent of the price from the drug companies – fees that are Read more about Quebec Implementing Single Purchaser for Generic Drugs[…]

Canadian Drug Companies Conflict of Interest in Clinical Practice Guidelines

Summary of the Globe and Mail Article The pressure of Big Pharma Financial conflicts of interest are commonplace on guideline committees; 46% of the panelists involved in nine guideline documents received funding from companies that might benefit from a positive mention of their drugs In 3 cases, more than 75 per cent of the panelists Read more about Canadian Drug Companies Conflict of Interest in Clinical Practice Guidelines[…]